(Q74015426)

English

The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen

scientific article published on 01 July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

based on heuristic

inferred from title

author name string

A M Billgren

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L E Rutqvist

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Johansson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Hägerström

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Skoog

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1374-1380

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cathepsin D and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adaptation of the Bradford protein assay to membrane-bound proteins by solubilizing in glucopyranoside detergents.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900114-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(00)00114-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10899650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74015426&oldid=1962148363"